Agenda – The Cannabis Partnerships Congress

  • Day One
  • Day Two

Day One

 Monday, March 12

8:45AM – 9:00AM

Conference Co-Chairpersons’ Opening Remarks
Dean Petkanas, Chief Medical Officer, KANNALIFE SCIENCES
Bruce Bloom, CEO, CURES WITHIN REACH

9:45AM – 10:30AM

Navigating Governmental and Ethics Requirements for Clinical Trials
Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, Chief Scientific Officer and Regulatory Affairs, TETRA BIO-PHARMA

10:30AM – 11:00AM

Networking Break

11:00AM – 11:45AM

Monitor Governmental Awareness and Legislative Research Options
Brian Fisher, Vice President of Operations and Corporate Partnerships, THE STURGE-WEBER FOUNDATION

11:45AM – 12:30PM

Review the Barriers and Routes to Success for Efficacy Research
Thoma Kikis, Chief Marketing Officer, KANNALIFE

12:30PM – 1:30PM

Luncheon

1:30PM – 2:30PM

Breakout Groups
Veronica Arroyave, Sr. Director, Global Health Programs, PARTNERSHIP FOR QUALITY MEDICAL DONATIONS
Dr. Bruno Battistini, President, CEO and Scientific Director, NEW BRUNSWICK HEALTH RESEARCH FOUNDATION
Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, Chief Scientific Officer and Regulatory Affairs, TETRA BIO-PHARMA

2:30PM – 3:15PM

Ensure Compliance in Cannabis Marketing
Darshan Kulkarni, Pharm.D., M.S., Esq., Advisor, AMERICAN SOCIETY OF CANNABIS PHARMACISTS

3:15PM – 4:00PM

Networking Break

4:00PM – 4:45PM

Understand Cannabis-Derived Medications Through the FDA Approval Process
Alice Mead, Vice President, U.S. Professional Relations, Greenwich Biosciences

4:45PM – 5:30PM

Interactive Partnerships Discussion: Maximize Strategic Partnerships in Order to Ensure Patient Safety and Launch a Successful Product
Dr. Bruno Battistini, President, CEO and Scientific Director, NEW BRUNSWICK HEALTH RESEARCH FOUNDATION


Day Two

 Tuesday, March 13

8:45AM – 9:00AM

Conference Co-Chairpersons’ Recap of Day One
Dean Petkanas, Chief Medical Officer, KANNALIFE SCIENCES
Bruce Bloom, CEO, CURES WITHIN REACH

9:00AM – 9:45AM

Understand Why State and Federal Governments Must Work Together to Align Regulations
Elias Jackson, Ph.D., Director of Scientific Public Relations, VYRIPHARM BIOPHARMACEUTICAL

9:45AM – 10:30AM

Forecast the Future of Lab Research in Cannabidiol and Improvements in Analytics and Quality
Barbara Read, Vice President of Sales and Marketing, Lifescript

10:30AM – 11:00AM

Networking Break

11:00AM – 11:45AM

Update QC and Patient Experience Communications for Medical Cannabis
Mark Reichman, EVP, Client Services Director, GUIDEMARK HEALTH; Cannabis Patient Advocate

11:45AM – 12:30PM

Innovative Treatments for Patients Through Drug Repurposing
Bruce Bloom, CEO, CURES WITHIN REACH

12:30PM – 1:30PM

Luncheon

1:30PM – 2:30PM

Regulatory Review: Current Legal Questions and Likely Future Developments
Lezli Engelking, President and Founder, FOCUS
Douglas Brenneman, Scientific Advisory Board, KANNALIFE SCIENCES
Jeremy Unruh, General Counsel and Chief Compliance Officer, PHARMACANN

2:30PM – 3:15PM

Integrate Medical Cannabis With Traditional Medicine
Jerry Bryant, Managing Member, VYRIPHARM BIOPHARMACEUTICAL

3:15PM – 4:00PM

Networking Break

4:00PM – 4:45PM

Utilize Crowdsourcing in Response to Federal Research Restrictions
Jeffrey Chen, Director, UCLA CANNABIS RESEARCH INITIATIVE